Yi Hong Liao
Net worth: 10 M $ as of 31/07/2026
Net worth: 10 M $ as of 31/07/2026
Yi Hong Liao is currently a Non-Executive Director at Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. since 2025 and a Member of the Supervisory Board at Sichuan Kelun Pharmacy Institute Co., Ltd. since 2020.
Formerly, Ms. Liao worked as an Audit Manager at Kpmg Consulting China Co. Ltd. from 2006 to 2014.
Education includes a graduate degree from Tsinghua University conferred in 2021 and an undergraduate degree from Guangdong University of Foreign Studies conferred in 2020.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/12/2025 | 170,000 ( 0.1% ) | 10 M $ | 31/07/2026 |
| Companies | Position | Start |
|---|---|---|
| SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. | Director/Board Member | 01/06/2025 |
Sichuan Kelun Pharmacy Institute Co., Ltd.
Sichuan Kelun Pharmacy Institute Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines | Director/Board Member | 05/11/2020 |
| Companies | Position | End |
|---|---|---|
Kpmg Consulting China Co. Ltd. | Comptroller/Controller/Auditor | 01/11/2014 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Tsinghua University
Tsinghua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Guangdong University of Foreign Studies
Guangdong University of Foreign Studies Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kpmg Consulting China Co. Ltd. | |
Sichuan Kelun Pharmacy Institute Co., Ltd.
Sichuan Kelun Pharmacy Institute Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines | Health Technology |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes drugs for treatment | Health Technology |
Select your edition
All financial news and data tailored to specific country editions